Frontlight ResearchEarly access
Trial site
Oncology Consultants, P.A.
- 13running trials
- 5closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Metastatic breast cancer4 trials
- Colorectal cancer3 trials
- Ovarian cancer3 trials
- Prostate cancer3 trials
- Endometrial cancer2 trials
- Kidney cancer2 trials
- Melanoma2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Cervical cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- and 5 more
- Phase
- Phase 38 trials
- Phase 1/24 trials
- Phase 13 trials
- Phase 22 trials
- Status
- Recruiting8 trials
- Active, not recruiting5 trials
- Completed3 trials
- Terminated2 trials
- Lead sponsor
- Pfizer4 trials
- Eli Lilly and Company3 trials
- EMD Serono Research & Development Institute, Inc.2 trials
- Daiichi Sankyo1 trial
- GV20 Therapeutics1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Recruiting
Recruiting
Active, not recruiting
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Active, not recruiting
Active, not recruiting
U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Colorectal cancer3 recruiting
- Endometrial cancer2 recruiting
- Melanoma2 recruiting
- Prostate cancer2 recruiting
- Cervical cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
Completed
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026